All the latest worldwide HIV and AIDS news, including treatment, prevention, and hepatitis and TB co-infections. News from our own team of writers plus articles we have selected from other sources.

aidsmap hiv & aids news


← First12345...843Next →

hiv & aids news selected from other sources

  • PrEP
    A Blue Pill Is Stopping HIV, World-First Study Shows
    Bloomberg | 2 hours ago

    An antiviral pill taken daily by thousands of men across Sydney and other parts of Australia led to a globally unprecedented reduction in new HIV cases, showing that a targeted, preventative approach may accelerate progress on ending the AIDS epidemic.

  • Undetectable viral load and treatment as prevention
    Becoming a parent should not be denied to HIV positive gay and bisexual men
    Gay Times | 23 hours ago

    If a man cannot pass HIV onto another man during sex because his viral load is undetectable, then it follows that his sperm would not pass HIV to a surrogate or child should he wish to conceive in this way. Even as a well informed HIV activist, this is an aspect of the U=U debate which I had not come across before in the context of same-sex couples.

  • Selt-testing and home testing
    Regulator seizes almost 10000 unsafe STI + HIV test kits
    GOV.UK | 17 October 2018

    The Medicines and Healthcare products Regulatory Agency (MHRA) is warning people who buy STI test kits and HIV test kits online to make sure that they are purchasing from safe and legitimate sources

  • Access to medicines and treatment
    South Africa: Shortage of HIV/Aids drugs turning into ‘national crisis’
    The Citizen | 16 October 2018

    ARVs and contraceptives have run out across the country in ‘a crisis that has been developing over the past two months’, the Stop Stockout Project claims.

  • Starting treatment
    Rapid Initiation of HIV Care: Assessing Safety and Efficacy
    Infectious Disease Advisor | 16 October 2018

    Discussion with Gregory Huhn, MD

  • Harm reduction
    Canada to invest $8.5 million in harm reduction projects for HCV, HIV
    Healio | 16 October 2018

    Canadian Minister of Health announced that the Government of Canada will fund 28 projects across the country designed to reduce the risk for bloodborne infections among people who use injection drugs such as hepatitis C and HIV, according to a press release.

  • Hepatitis C treatment
    Vosevi safe, effective in ‘triple-infected’ patients with HCV, HBV, HIV
    Healio | 15 October 2018

    The direct-acting antiviral Vosevi demonstrated an average sustained virologic response rate of 87% among patients who were “triple-infected” with hepatitis C genotype 3, hepatitis B and HIV, as presented at the American College of Gastroenterology Annual Meeting.

  • Support issues for children and young people
    Adolescents and HIV: kindness and time key factors for treatment retention
    AVERT | 15 October 2018

    New research from South Africa provides insights into the factors associated with retention of adolescents in HIV care, suggesting relatively low‐cost interventions could significantly improve adherence and retention in care.

  • PrEP policies and guidelines
    My PrEP Story: Will
    Prepster | 12 October 2018

    As the IMPACT Trial hits its first anniversary, PrEPster co-founder Will Nutland says that the waiting needs to stop: full implementation of PrEP must become a priority.

  • Neurological and cognitive problems
    ART Reduces Neurocognitive Impairment in Patients Living With HIV
    Infectious Disease Advisor | 12 October 2018

    Initiating antiretroviral therapy (ART) may reduce the risk for neurocognitive impairment in patients living with HIV, according to study results published in Clinical Infectious Diseases.

← First12345...12Next →

Conference news

News from the 22nd International AIDS Conference (AIDS 2018).

HIV update

Sign up for HIV update, our fortnightly news bulletin for people living with HIV in the UK.

Achieving the 90-90-90 target

With advances in HIV testing, treatment and care, some countries are making great progress towards the UNAIDS 90-90-90 target.

New EUROBulletin

Read the August edition of the Sexual Health & HIV Policy EUROBulletin.

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.